Nafamostat
From Self-sufficiency
| File:Nafamostat.png | |
| Systematic (IUPAC) name | |
|---|---|
|
6-[amino(imino)methyl]-2-naphthyl 4-{[amino(imino)methyl]amino}benzoate | |
| Clinical data | |
| Routes of administration | IV |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 81525-10-2 |
| ATC code | none |
| PubChem | CID 4413 |
| Chemical data | |
| Formula | C19H17N5O2 |
| Molar mass | 347.37 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Nafamostat (INN) is an anticoagulant.
| 40px | This drug article relating to the blood and blood forming organs is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Anticoagulants
- Blood and blood forming organ drug stubs
- 2Fix
